Neurocognitive Disorders, the DSM-5, and Informed Treatment Choices

Stuart SchlossmanMS Research Study and Reports

Statement of Need

Changes to the DSM-5 have modified the language used in evidence-based diagnostic criteria for dementia (1) and education for clinicians can accelerate both the adoption of this new language and how to apply these revisions to clinical practice.  (1) The National Institutes of Health’s (NIH) National Institute on Aging Alzheimer’s Disease (NIAAD) Research Summit 2013 reported that the management of Alzheimer’s disease needs to be viewed as a continuum that begins up to one decade before the symptoms form an obvious, clinical entity. The Summit further reported that Alzheimer’s disease is a multifaceted disease, and there is much more that clinicians can do much more than they currently over the course of the disease to work to change its course.(2)
This enduring replay of the symposium presented at the AAGP Annual Meeting in Orlando, Florida will update clinicians on the new diagnostic language for neurocognitive disorders in DSM-5 for neurocognitive disorders and through the use of an interactive case challenge, demonstrate the implications of these changes for optimizing and informing clinical practice.
For the clinician or others, read more

~~~~~~~~~~~~~~~~~~~~
 Keep CURRENT and up to date, with MS News and Information
Sign-up for emails 

.

WATCH OUR MS EDUCATIONAL VIDEOS by Topic, 

.

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews